12. Juni 2019Podcast

ASCO 2019 Podcast: Highlights from Five Swiss Experts

An image

Abstracts discussed in this podcast:

Lung cancer
Head and Neck Cancer
  • Rischin D et al. Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).Abstract 6000
Genitourinary Cancers